IQVIA Holdings (MEX:IQV) EBIT: MXN42,981 Mil (TTM As of Mar. 2026)


MEX:IQV IQVIA Holdings Inc MEX:IQV
76 GF Score
Price MXN3,000.00
GF Value MXN4,238.79
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings EBIT?

IQVIA Holdings MEX:IQV 76 EBIT is MXN42,981 Mil as of Mar. 2026. GuruFocus rates MEX:IQV with a GF Score™ of 76/100 and a GF Value™ of MXN4,238.79 (Modestly Undervalued). The stock has 3 warning signs investors should review.

IQVIA Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was MXN9,377 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN42,981 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. IQVIA Holdings's annualized ROC % for the quarter that ended in Mar. 2026 was 6.51%. IQVIA Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 255.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. IQVIA Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.43%.


IQVIA Holdings  (MEX:IQV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

IQVIA Holdings's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=40753.904 * ( 1 - 17.99% )/( (522939.546 + 504428.717)/ 2 )
=33422.2766704/513684.1315
=6.51 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=539162.681 - 53837.043 - ( 38550.204 - max(0, 150131.527 - 112517.619+38550.204))
=522939.546

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=535120.373 - 68722.62 - ( 37922.768 - max(0, 150194.358 - 112163.394+37922.768))
=504428.717

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

IQVIA Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=37508.016/( ( (14818.691 + max(-74705.65, 0)) + (14588.454 + max(-74132.43, 0)) )/ 2 )
=37508.016/( ( 14818.691 + 14588.454 )/ 2 )
=37508.016/14703.5725
=255.09 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(30033.508 + 0 + 12261.881) - (53837.043 + 38136.073 + 25027.923)
=-74705.65

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(29429.366 + 0 + 13380.263) - (68722.62 + 40771.935 + 7447.504)
=-74132.43

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

IQVIA Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=42981.398/791413.095
=5.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IQVIA Holdings EBIT Related Terms


IQVIA Holdings EBIT Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings EBIT Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,832.54 34,683.38 36,172.12 48,781.48 41,773.22

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,983.60 9,508.75 10,951.49 13,144.16 9,377.00

MEX:IQV vs NTRA, ILMN, MTD: EBIT Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's EV-to-EBIT falls into.


MEX:IQV
76GF Score
IQVIA Holdings Inc MEX:IQV
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN42,981 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN42,981 Mil mean?
IQVIA Holdings (MEX:IQV) has a EBIT of MXN42,981 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IQVIA Holdings.
Is IQVIA Holdings' EBIT too high?
IQVIA Holdings' current EBIT is MXN42,981 Mil. Overall, IQVIA Holdings has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' EBIT compare to NTRA and ILMN?
IQVIA Holdings' EBIT of MXN42,981 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IQVIA Holdings. IQVIA Holdings's current EBIT is MXN42,981 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (MEX:IQV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN4,238.79, compared to a current price of MXN3,000.00 — trading 29.2% below its estimated fair value. The current EBIT is MXN42,981 Mil. IQVIA Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For IQVIA Holdings (MEX:IQV), the current EBIT is MXN42,981 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (MEX:IQV) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of MXN3,000.00 is trading 29.2% below its estimated GF Value™ of MXN4,238.79. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for MEX:IQV:

  • EBIT: MXN42,981 Mil
  • GF Value™: MXN4,238.79 vs. price of MXN3,000.00 (29.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the MEX:IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
76GF Score

Get the complete analysis for MEX:IQV

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,000.00
Price
MXN4,238.79
GF Value